D
Davide Negrini
Researcher at University of Padua
Publications - 11
Citations - 562
Davide Negrini is an academic researcher from University of Padua. The author has contributed to research in topics: Medicine & Plaque reduction neutralization test. The author has an hindex of 4, co-authored 7 publications receiving 347 citations.
Papers
More filters
Journal ArticleDOI
IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study.
Andrea Padoan,Laura Sciacovelli,Daniela Basso,Davide Negrini,Silvia Zuin,Chiara Cosma,Diego Faggian,Paolo Maria Matricardi,Mario Plebani +8 more
TL;DR: The kinetics of IgM, IgA and IgG SARS-CoV-2 antibodies in COVID-19 patients with confirmed (rRT-PCR) infection found that the IgA response appears and grows early, peaks at week 3, and it is stronger and more persistent than the IgM response.
Journal ArticleDOI
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity.
Andrea Padoan,Francesco Bonfante,Matteo Pagliari,Alessio Bortolami,Davide Negrini,Silvia Zuin,Dania Bozzato,Chiara Cosma,Laura Sciacovelli,Mario Plebani +9 more
TL;DR: All immunoassays had an excellent specificity, whereas sensitivity varied across immunosorbent assays, depending strongly on the time interval between symptoms onset and sample collection, according to the SARS-CoV-2 virus.
Journal ArticleDOI
Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays?
TL;DR: The results obtained indicate that, for CLIA assays, it might be possible to define thresholds that improve the negative likelihood ratio, and improved the overall inter-assay agreement, paving the way to a better harmonization of serologic tests.
Posted ContentDOI
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity
Andrea Padoan,Francesco Bonfante,Matteo Pagliari,Alessio Bortolami,Davide Negrini,Silvia Zuin,Dania Bozzato,Chiara Cosma,Laura Sciacovelli,Mario Plebani +9 more
TL;DR: All immunoassays had an excellent specificity, whereas sensitivity varied across immuno assays, depending strongly on the time interval between symptoms onset and sample collection, according to the SARS-CoV-2 virus.
Journal ArticleDOI
Homocysteine in coronavirus disease (COVID-19): a systematic literature review
TL;DR: Despite the limited evidence that has been garnered so far, increased homocysteine levels may be a potentially useful marker for predicting the risk of unfavorable progression in patients with COVID-19.